v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Non-voting Common Stock
Voting Common Stock
Common Stock
Common Stock
Non-voting Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balances at Dec. 31, 2024 $ 240,970     $ 5 $ 1 $ 616,009 $ 51 $ (375,096)
Balances, shares at Dec. 31, 2024       52,314,039 4,276,588      
Issuance of common stock under employee stock purchase plan 191         191    
Issuance of common stock under employee stock purchase plan, shares       157,366        
Stock-based compensation expense 6,687         6,687    
Net loss (71,079)             (71,079)
Unrealized loss on available-for-sale securities (55)           (55)  
Balances at Jun. 30, 2025 176,714     $ 5 $ 1 622,887 (4) (446,175)
Balances, shares at Jun. 30, 2025       52,471,405 4,276,588      
Balances at Mar. 31, 2025 210,202     $ 5 $ 1 619,423 (4) (409,223)
Balances, shares at Mar. 31, 2025       52,314,039 4,276,588      
Issuance of common stock under employee stock purchase plan 191         191    
Issuance of common stock under employee stock purchase plan, shares       157,366        
Stock-based compensation expense 3,273         3,273    
Net loss (36,952)             (36,952)
Unrealized loss on available-for-sale securities 0           0  
Balances at Jun. 30, 2025 176,714     $ 5 $ 1 622,887 $ (4) (446,175)
Balances, shares at Jun. 30, 2025       52,471,405 4,276,588      
Balances at Dec. 31, 2025 123,123     $ 5 $ 1 627,979   (504,862)
Balances, shares at Dec. 31, 2025   4,276,588 52,625,035 52,625,035 4,276,588      
Issuance of common stock upon exercise of pre-funded warrants       $ 2   (2)    
Issuance of common stock upon exercise of pre-funded warrants, shares       10,763,977        
Issuance of common stock under employee stock purchase plan 99         99    
Issuance of common stock under employee stock purchase plan, shares       113,655        
Stock-based compensation expense 4,822         4,822    
Net loss (59,025)             (59,025)
Balances at Jun. 30, 2026 69,019     $ 7 $ 1 632,898   (563,887)
Balances, shares at Jun. 30, 2026   4,276,588 63,502,667 63,502,667 4,276,588      
Balances at Mar. 31, 2026 96,922     $ 6 $ 1 630,443   (533,528)
Balances, shares at Mar. 31, 2026       55,824,722 4,276,588      
Issuance of common stock upon exercise of pre-funded warrants 0     $ 1   (1)    
Issuance of common stock upon exercise of pre-funded warrants, shares       7,564,290        
Issuance of common stock under employee stock purchase plan 99         99    
Issuance of common stock under employee stock purchase plan, shares       113,655        
Stock-based compensation expense 2,357         2,357    
Net loss (30,359)             (30,359)
Unrealized loss on available-for-sale securities 0              
Balances at Jun. 30, 2026 $ 69,019     $ 7 $ 1 $ 632,898   $ (563,887)
Balances, shares at Jun. 30, 2026   4,276,588 63,502,667 63,502,667 4,276,588